Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers

por Dusselier, Matthieu, Deluche, Elise, Delacourt, Nellie, Ballouhey, Julia, Egenod, Thomas, Melloni, Boris, Vergnenègre, Charlotte, Veillon, Rémi, Vergnenègre, Alain
Publicado 2019

Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study

por Heraudet, Luc, Delon, Tara, Veillon, Rémi, Vergnenègre, Charlotte, Lepetit, Hélène, Daste, Amaury, Ravaud, Alain, Zysman, Maéva, Domblides, Charlotte
Publicado 2022

A Prospective Study to Detect Immune Checkpoint Inhibitors Associated With Myocarditis Among Patients Treated for Lung Cancer

por Faubry, Clara, Faure, Maxime, Toublanc, Anne-Claire, Veillon, Rémi, Lemaître, Anne-Iris, Vergnenègre, Charlotte, Cochet, Hubert, Khan, Sadia, Raherison, Chantal, Dos Santos, Pierre, Zysman, Maeva
Publicado 2022